Faheem Hasnain, Director of Kura Oncology KURA, has filed 5 purchases and 3 sales on the open market. Over the past 12 months that comes to a net sale of $109.8K. The latest trade was on 06/04.

FH

FH

Faheem Hasnain

Director

Company

Kura Oncology KURA

First filing

23/01/24

Trades

53 trades

Buys / sales

5 / 3

12-month net buying

−$109.8K

Last trade

06/04

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Kura OncologyKURA	Open-market sale	25/12/09	25/12/10	10,000 sh	$10.98	$109,800	−29.4%
Kura OncologyKURA	Open-market sale	25/03/21	25/03/24	22,682 sh	$8.00	$181,456	−48.6%
Gossamer BioGOSS	Open-market buy	24/06/21	24/06/24	372,000 sh	$0.67	$249,240	+7.4%
Gossamer BioGOSS	Open-market sale	24/03/27	24/03/28	23,172 sh	$1.16	$26,879.52	−16.2%
MT Mirati Therapeutics	Open-market buy	23/08/11	23/08/14	10,791 sh	$27.80	$299,989.8	No record
Gossamer BioGOSS	Open-market buy	23/03/20–23/03/22	23/03/22	878,572 sh3 trades	$1.14avg.	$999,180.29	+24.3%